Microsatellite Stable Rectal Carcinoma — Trials

Microsatellite Stable Rectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Dana-Farber Cancer Institute
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07735624	RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer(RECTIFY-1)	recruiting	Phase 2	16	Dana-Farber Cancer InstituteOTHER	1	Aug 18, 2026	clinicaltrials
NCT06843434	A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma	recruiting	Phase 2	40	Memorial Sloan Kettering Cancer CenterOTHER	1	Jun 16, 2026	clinicaltrials